1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
Beta-lactam and Beta-lactamase Inhibitors Market by Drug Class, Disease and Route of Administration: Global Opportunity Analysis and Industry Forecast, 2019-2028

Beta-lactam and Beta-lactamase Inhibitors Market by Drug Class, Disease and Route of Administration: Global Opportunity Analysis and Industry Forecast, 2019-2028

  • August 2019
  • 309 pages
  • ID: 5816614
  • Format: PDF
  • By Allied Market Research

Summary

Table of Contents

Beta-lactam and Beta-lactamase Inhibitors Market by Drug Class (Penicillin, Cephalosporin, Carbapenem, Monobactam, and Combination), Disease (Urinary Tract Infection, Respiratory Infection, Skin Infection, Complicated Urinary Tract Infection (cUTI), Complicated Intra-Abdominal Infections (cIAI), Nosocomial Pneumonia, Blood Stream Infection, and Other Diseases), and Route of Administration (Oral, Intravenous, and Other Route of Administrations): Global Opportunity Analysis and Industry Forecast, 2019–2028

The global beta-lactam and beta-lactamase inhibitors market size was $27,126 million in 2018, and is projected to reach $34,170 million by 2028, growing at a CAGR of 2.3% from 2019 to 2028.

Beta-lactam and beta-lactamase inhibitors is a most important type of antibacterial agent used for fighting bacterial infections. In addition, these are used to kill or prevent the growth of microorganisms. Based on the molecular structure, beta-lactam and beta-lactamase inhibitors are drug classified into penicillin, cephalosporin, carbapenem, monobactam, and combination.

There is an increase in the demand for beta-lactam and beta-lactamase inhibitors, owing to increased consumption in low- and middle-income countries (LMICs) and rise in prevalence of infectious diseases. In addition, development of novel approaches for new beta-lactam and beta-lactamase inhibitors for treating bacterial infections and a large number of clinical trials further drive the market growth. However, development of antibiotic resistance, driven by misuse of beta-lactam and beta-lactamase inhibitors and the time taken for the regulatory approval is projected to impede the market growth. On the contrary, discovery of advanced prospect molecules and novel combination therapies to treat antibiotic-resistant microbial infections are expected to offer significant profitable opportunities for the market players.

The global beta-lactam and beta-lactamase inhibitors market is segmented based on drug class, disease, route of administration, and region. Based on the drug class, the market is classified into penicillin, cephalosporin, carbapenem, monobactam, and combination. Combination segment is further categorized into penicillin/beta lactamase inhibitors, cephalosporins/beta lactamase inhibitors, and carbapenems/beta lactamase inhibitors. Depending on the disease segment, the market is divided into urinary tract infection (excluding cUTI), respiratory infection, skin infection, complicated urinary tract infection (cUTI), complicated intra-abdominal infections (cIAI), nosocomial pneumonia, blood stream infection, and other diseases. Nosocomial pneumonia segment is further divided into hospital acquired pneumonia, ventilator associated pneumonia, and other nosocomial pneumonia. Based on route of administration, the market is classified into oral, intravenous, and others. Based on region, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS
-This report provides a detailed quantitative analysis of the current market trends and future estimations from 2019 to 2028, which assists to identify the prevailing market opportunities.
-An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
-A comprehensive analysis of the factors that drive and restrain the growth of the global beta-lactam and beta-lactamase inhibitors market is provided.
-An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.

KEY MARKET SEGMENTS
•By Drug Class
oPenicillin
oCephalosporin
oCarbapenem
oMonobactam
oCombination
-Penicillin/Beta Lactamase Inhibitors
-Cephalosporins/Beta Lactamase Inhibitors
-Carbapenems/Beta Lactamase Inhibitors
•By Disease
oUrinary Tract Infection (excluding cUTI)
oRespiratory Infection
oSkin Infection
oComplicated Urinary Tract Infection (cUTI)
oComplicated Intra-Abdominal Infections (cIAI)
oNosocomial Pneumonia
-Hospital Acquired Pneumonia
-Ventilator Associated Pneumonia
-Other Nosocomial Pneumonia
oBlood Stream Infection
oOther Diseases
•By Route of Administration
oOral
oIntravenous
oOthers
•By Region
oNorth America
-U.S.
-Canada
-Mexico
oEurope
-Germany
-France
-Spain
-Italy
-UK
-Rest of Europe
oAsia-Pacific
-Japan
-India
-China
-South Korea
-Thailand
-Taiwan
-Vietnam
-Rest of Asia-Pacific
oLAMEA
-Brazil
-Saudi Arabia
-South Africa
-Rest of LAMEA

KEY MARKET PLAYERS
•Abbott Laboratories
•Allergan Plc.
•F. Hoffmann-La Roche Ltd.
•GlaxoSmithKline plc
•Merck & Co. Inc.
•Mylan N.V.
•Novartis International AG (Sandoz)
•Pfizer Inc.
•Sanofi
•Teva Pharmaceutical Industries Ltd.

The other players in the value chain (profiles not included in the report)
•Hikma Pharmaceuticals
•Melinta Therapeutics
•Eli Lilly and Company
•Shionogi, Inc.
•AstraZeneca plc

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Veronica helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Swabs Market by Application and Geography - Forecast and Analysis 2019-2023

Swabs Market by Application and Geography - Forecast and Analysis 2019-2023

  • $ 2500
  • October 2019

Global Swabs Market: About this marketThis swabs market analysis considers sales from medical, industrial, and other applications. Our study also finds the sales of swabs in Asia, Europe, North America, ...

Global Bioelectric Medicine Market: Focus on Product, 11 Countries’ Data, and Competitive Landscape – Analysis and Forecast, 2019-2025

Global Bioelectric Medicine Market: Focus on Product, 11 Countries’ Data, and Competitive Landscape – Analysis and Forecast, 2019-2025

  • $ 5000
  • October 2019

Global Bioelectric Medicine Market to Reach $29,125.8 Million by 2025Key Questions Answered in this Report:• What are the different types of bioelectric medicine available in the market and what are ...

MRI Coils Market by Patient Type and Geography - Global Forecast & Analysis 2019-2023

MRI Coils Market by Patient Type and Geography - Global Forecast & Analysis 2019-2023

  • $ 2500
  • October 2019

Global MRI Coils Market: About this marketThis MRI coils market analysis considers sales from both adult and pediatric types. Our analysis also considers the sales of MRI coils in Asia, Europe, North America, ...

Disinfectants Markets in China $ 4000 October 2019


ref:plp2019

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on